Einzeltreffer — DigiBib

Background: Hypertension is the leading global risk factor for mortality. Hypertension treatment and control rates are low worldwide, and delays in seeking care are associated with increased mortality. Thus, a critical component of hypertension management is to optimize linkage and retention to care.

Methods/design: This study investigates whether community health workers, equipped with a tailored behavioral communication strategy and smartphone technology, can increase linkage and retention of hypertensive individuals to a hypertension care program and significantly reduce blood pressure among them. The study will be conducted in the Kosirai and Turbo Divisions of western Kenya. An initial phase of qualitative inquiry will assess facilitators and barriers of linkage and retention to care using a modified Health Belief Model as a conceptual framework. Subsequently, we will conduct a cluster randomized controlled trial with three arms: 1) usual care (community health workers with the standard level of hypertension care training); 2) community health workers with an additional tailored behavioral communication strategy; and 3) community health workers with a tailored behavioral communication strategy who are also equipped with smartphone technology. The co-primary outcome measures are: 1) linkage to hypertension care, and 2) one-year change in systolic blood pressure among hypertensive individuals. Cost-effectiveness analysis will be conducted in terms of costs per unit decrease in blood pressure and costs per disability-adjusted life year gained.

Discussion: This study will provide evidence regarding the effectiveness and cost-effectiveness of strategies to optimize linkage and retention to hypertension care that can be applicable to non-communicable disease management in low- and middle-income countries.

Trial Registration: This trial is registered with (NCT01844596) on 30 April 2013.

Titel:	Optimizing linkage and retention to hypertension care in rural Kenya (LARK hypertension study): study protocol for a randomized controlled trial.
Autor/in / Beteiligte Person:	Vedanthan, R ; Kamano, JH ; Naanyu, V ; Delong, AK ; Were, MC ; Finkelstein, EA ; Menya, D ; Akwanalo, CO ; Bloomfield, GS ; Binanay, CA ; Velazquez, EJ ; Hogan, JW ; Horowitz, CR ; Inui, TS ; Kimaiyo, S ; Fuster, V
Link:	Full Text Finder (Volltext)
Zeitschrift:	Trials, Jg. 15 (2014-04-27), S. 143
Veröffentlichung:	[London] : BioMed Central, 2006-, 2014
Medientyp:	academicJournal
ISSN:	1745-6215 (electronic)
DOI:	10.1186/1745-6215-15-143
Schlagwort:	Black People psychology Blood Pressure Cell Phone Clinical Protocols Communication Cost-Benefit Analysis Health Care Costs Health Knowledge, Attitudes, Practice Humans Hypertension diagnosis Hypertension economics Hypertension ethnology Hypertension physiopathology Hypertension psychology Kenya epidemiology Motivational Interviewing Patient Compliance Professional-Patient Relations Time Factors Treatment Outcome Community Health Services economics Community Health Workers economics Health Behavior Hypertension therapy Patients psychology Research Design Rural Health Services economics
Sonstiges:	Nachgewiesen in: MEDLINE Sprachen: English Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural Language: English [Trials] 2014 Apr 27; Vol. 15, pp. 143. <i>Date of Electronic Publication: </i>2014 Apr 27. MeSH Terms: Community Health Services* / economics ; Community Health Workers* / economics ; Health Behavior* ; Research Design* ; Rural Health Services* / economics ; Hypertension / therapy ; Patients / psychology ; Black People / psychology ; Blood Pressure ; Cell Phone ; Clinical Protocols ; Communication ; Cost-Benefit Analysis ; Health Care Costs ; Health Knowledge, Attitudes, Practice ; Humans ; Hypertension / diagnosis ; Hypertension / economics ; Hypertension / ethnology ; Hypertension / physiopathology ; Hypertension / psychology ; Kenya / epidemiology ; Motivational Interviewing ; Patient Compliance ; Professional-Patient Relations ; Time Factors ; Treatment Outcome References: J Hypertens. 2013 May;31(5):1018-24. (PMID: 23425703) ; J Pharm Pharm Sci. 2004 Nov 12;7(3):350-2. (PMID: 15576016) ; Epilepsy Behav. 2012 Dec;25(4):614-21. (PMID: 23160097) ; Mt Sinai J Med. 2011 May-Jun;78(3):303-5. (PMID: 21598257) ; J Womens Health (Larchmt). 2006 May;15(4):379-89. (PMID: 16724886) ; PLoS One. 2012;7(3):e32638. (PMID: 22427857) ; Ethn Dis. 2009 Winter;19(1):35-41. (PMID: 19341161) ; Glob Public Health. 2011;6(3):247-56. (PMID: 21390970) ; JAMA. 2003 May 21;289(19):2560-72. (PMID: 12748199) ; J Hypertens. 2009 May;27(5):963-75. (PMID: 19402221) ; Lancet. 2007 Dec 22;370(9605):2158-63. (PMID: 17574662) ; Acad Med. 2007 Aug;82(8):812-8. (PMID: 17762264) ; J Acquir Immune Defic Syndr. 2009 Nov;52 Suppl 1:S54-7. (PMID: 19858941) ; Lancet. 2005 Jan 15-21;365(9455):217-23. (PMID: 15652604) ; J Hypertens. 2003 Nov;21(11):1983-92. (PMID: 14597836) ; Am J Hypertens. 2008 Oct;21(10):1137-43. (PMID: 18654123) ; Ann Intern Med. 2009 Nov 3;151(9):593-601. (PMID: 19884620) ; J Gen Intern Med. 2007 Dec;22(12):1745-50. (PMID: 17972138) ; Health Promot Pract. 2011 Jul;12(4):538-43. (PMID: 21051326) ; Global Health. 2013 May 16;9:21. (PMID: 23680083) ; BMC Public Health. 2010 Sep 22;10:569. (PMID: 20860807) ; N Engl J Med. 2005 May 19;352(20):2091-9. (PMID: 15901862) ; Lancet. 2012 Dec 15;380(9859):2224-60. (PMID: 23245609) ; Lancet. 2002 Dec 14;360(9349):1903-13. (PMID: 12493255) ; J Womens Health (Larchmt). 2004 Jun;13(5):625-33. (PMID: 15257854) ; Cardiovasc J Afr. 2011 Jan-Feb;22(1):31-5. (PMID: 21298203) ; BMC Med Res Methodol. 2006 May 03;6:20. (PMID: 16672056) ; Qual Health Res. 2011 Jan;21(1):14-26. (PMID: 20435788) ; Trop Med Int Health. 2011 Oct;16(10):1276-84. (PMID: 21733046) ; Int J Med Inform. 2010 Mar;79(3):204-10. (PMID: 20089444) ; Res Social Adm Pharm. 2009 Dec;5(4):363-75. (PMID: 19962679) ; Am Heart J. 2011 May;161(5):842-7. (PMID: 21570512) ; Health Econ. 2001 Dec;10(8):779-87. (PMID: 11747057) ; Pers Soc Psychol Rev. 2007 May;11(2):167-203. (PMID: 18453461) ; J Hypertens. 2009 Jul;27(7):1472-7. (PMID: 19474763) ; BMJ. 2008 Jun 28;336(7659):1475-82. (PMID: 18573856) Grant Information: R24 HD041020 United States HD NICHD NIH HHS; U01 HL114200 United States HL NHLBI NIH HHS; P30 AI042853 United States AI NIAID NIH HHS; K01 TW009218 United States TW FIC NIH HHS; K01 TW 009218 - 03 United States TW FIC NIH HHS Molecular Sequence: ClinicalTrials.gov NCT01844596 Entry Date(s): Date Created: 20140429 Date Completed: 20150219 Latest Revision: 20221207 Update Code: 20231215 PubMed Central ID: PMC4113229

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

BibTeX Citavi, JabRef, u.a.
(Literaturverwaltung)

PDF kein Volltext!
(Merkzettel, Notizen)

RIS Endnote, Citavi u.a.
(Literaturverwaltung)

MODS
(XML zur Weiterverarbeitung)

oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

Gewünschter Zitations-Stil:

oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.

Optimizing linkage and retention to hypertension care in rural Kenya (LARK hypertension study): study protocol for a randomized controlled trial.